VIIBRYD DIN 02443759
Health Canada record
| Active ingredient(s) | VILAZODONE HYDROCHLORIDE 10 MG; VILAZODONE HYDROCHLORIDE 20 MG |
|---|---|
| Dosage form | Kit; Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | N06AX24 VILAZODONE |
| Original market date | 06-Jul-2018 |
| Current status date | 20-Jul-2023 |
| Source | Health Canada DPD |
Establishment licence of the holder
AbbVie Corporation — licence 101988, currently licensed, last inspection rating C (2023-07-18).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing VILAZODONE HYDROCHLORIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02551810 | APO-VILAZODONE | APOTEX INC | Tablet | VILAZODONE HYDROCHLORIDE 10 MG | Marketed |
| 02551837 | APO-VILAZODONE | APOTEX INC | Tablet | VILAZODONE HYDROCHLORIDE 40 MG | Marketed |
| 02551829 | APO-VILAZODONE | APOTEX INC | Tablet | VILAZODONE HYDROCHLORIDE 20 MG | Marketed |
| 02568705 | PMS-VILAZODONE | PHARMASCIENCE INC | Tablet | VILAZODONE HYDROCHLORIDE 40 MG | Approved |
| 02568683 | PMS-VILAZODONE | PHARMASCIENCE INC | Tablet | VILAZODONE HYDROCHLORIDE 10 MG | Approved |
| 02568691 | PMS-VILAZODONE | PHARMASCIENCE INC | Tablet | VILAZODONE HYDROCHLORIDE 20 MG | Approved |
| 02443732 | VIIBRYD | ABBVIE CORPORATION | Tablet | VILAZODONE HYDROCHLORIDE 20 MG | Marketed |
| 02443724 | VIIBRYD | ABBVIE CORPORATION | Tablet | VILAZODONE HYDROCHLORIDE 10 MG | Marketed |
| 02443740 | VIIBRYD | ABBVIE CORPORATION | Tablet | VILAZODONE HYDROCHLORIDE 40 MG | Marketed |
| 02443767 | VIIBRYD | FOREST LABORATORIES CANADA INC | Kit; Tablet | VILAZODONE HYDROCHLORIDE 10 MG; VILAZODONE HYDROCHLORIDE 20 MG; VILAZODONE HYDROCHLORIDE 40 MG | Cancelled Pre Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 29513 | 2022-11-21 | New Drug Submission (NDS) | Administrative: Merger/Buy-out |
| 17096 | 2015-07-16 | New Drug Submission (NDS) |
International API supply for VILAZODONE HYDROCHLORIDE
15 active FDA Drug Master Files.
Request a quote for VIIBRYD